Key result
Newer prognostic markers for soft tissue sarcoma may improve prognostication at diagnosis and help select high-risk patients who could benefit from adjuvant therapy.
Population
Patients with soft tissue sarcoma (STS)
Design
Review
Authors
Loading...
May refine risk stratification in soft tissue sarcoma; leaves open prospective validation before guiding adjuvant therapy.
This review summarizes current and emerging prognostic factors for soft tissue sarcoma to improve prognostication and selection for adjuvant therapy.
Edward A. Levine (1999) conducted a review in Soft tissue sarcoma. Prognostic factors (AJCC staging system, clinical factors, newer markers) was evaluated. Newer prognostic markers for soft tissue sarcoma may improve prognostication at diagnosis and help select high-risk patients who could benefit from adjuvant therapy.